Key result
Permanent and persistent atrial fibrillation increased the likelihood of receiving oral anticoagulants compared with paroxysmal atrial fibrillation.
Why the study?
Benefits of oral anticoagulants in AF patients with moderate-to-high risk of stroke are independent of AF pattern, but whether clinical subtype influences anticoagulant use in older populations remains unclear.
Does atrial fibrillation subtype influence the likelihood of receiving oral anticoagulant therapy in an older population?
Cross-Sectional (n=319)
Yes
Does atrial fibrillation subtype influence the likelihood of receiving oral anticoagulant therapy in an older population?
Despite guidelines recommending oral anticoagulation based on stroke risk regardless of AF pattern, patients with paroxysmal AF are significantly less likely to receive oral anticoagulants compared to those with persistent or permanent AF.
Answers are grounded in this paper and cite their sources.
Paroxysmal AF may be undertreated with OACs in older adults; leaves open whether AF pattern influences real-world prescribing.
BACKGROUND AND AIM: Benefits of oral anticoagulants (OAC) in atrial fibrillation (AF) patients with moderate-to-high risk of stroke are independent of AF pattern. We evaluated whether AF clinical subtype influenced OAC use in a representative sample of the Italian older population. METHODS: A cross-sectional examination of all subjects aged 65 + years from three general practices in northern, central, and southern Italy started in 2016. A double-screening procedure was followed by clinical and ECG confirmation. Patients were categorized as having paroxysmal, persistent, or permanent AF. OAC use was evaluated in confirmed AF patients. RESULTS: The sample included 6016 subjects. Excluding 235 non-eligible, participation was 78.3%, which left 4528 participants (mean age 74.5 ± 6.8 years, 47.2% men). Overall, 319 AF cases were identified: 43.0% had paroxysmal, 21.3% persistent, and 35.7% permanent AF. Frequency of OAC therapy was 91.2% in permanent, 85.3% in persistent, and only 43.0% in paroxysmal AF (P < 0.001). In multivariate analysis, controlled for baseline variables and risk scales, persistent and permanent AF were associated with a significant increase in the likelihood of receiving OAC compared with paroxysmal AF (P < 0.001). This was confirmed for permanent AF also in multivariate analyses considering separately vitamin K antagonists or direct-acting oral anticoagulants (OR, 4.37, 95% CI, 2.43-7.85; and 1.92, 95% CI, 1.07-3.42, respectively) and for persistent AF and direct-acting oral anticoagulants (OR, 4.33, 95% CI, 2.30-8.15). CONCLUSIONS: In a population-based survey, AF pattern was an independent predictor of OAC treatment. Paroxysmal AF is still perceived as carrying a lower risk of vascular events.
No takes yet. Share an insight, caveat, or question.
Carlo et al. (2022) conducted a cross-sectional in Atrial fibrillation (n=319). Permanent atrial fibrillation vs. Paroxysmal atrial fibrillation was evaluated on Receipt of oral anticoagulant therapy (OR 12.44, 95% CI 5.87-26.33, p=<0.001). Permanent and persistent atrial fibrillation increased the likelihood of receiving oral anticoagulants compared with paroxysmal atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: